These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2143272)

  • 1. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?
    Martínez M
    Neurology; 1990 Aug; 40(8):1292-8. PubMed ID: 2143272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
    Martinez M
    Brain Res; 1992 Jun; 583(1-2):171-82. PubMed ID: 1504825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: severe deficiency of docosahexaenoic acid in Zellweger's and pseudo-Zellweger's syndromes.
    Martinez M
    World Rev Nutr Diet; 1991; 66():87-102. PubMed ID: 1828923
    [No Abstract]   [Full Text] [Related]  

  • 4. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.
    Moore SA; Hurt E; Yoder E; Sprecher H; Spector AA
    J Lipid Res; 1995 Nov; 36(11):2433-43. PubMed ID: 8656081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome.
    Martinez M
    Lipids; 1989 Apr; 24(4):261-5. PubMed ID: 2755305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
    Poulos A; Sharp P; Johnson D
    Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal-onset adrenoleukodystrophy.
    Black VH; Cornacchia L
    Am J Anat; 1986 Sep; 177(1):107-18. PubMed ID: 3776884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe changes in polyunsaturated fatty acids in the brain, liver, kidney, and retina in patients with peroxisomal disorders.
    Martinez M
    Adv Exp Med Biol; 1992; 318():347-59. PubMed ID: 1636502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of Zellweger's cerebrohepatorenal syndrome].
    Schutgens RB; Heymans HS; Purvis R; Wanders RJ; Schrakamp G; van den Bosch H
    Tijdschr Kindergeneeskd; 1984 Dec; 52(6):231-8. PubMed ID: 6528320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid analyses in "pseudo-Zellweger" syndrome; clues to the defect in peroxisomal beta-oxidation.
    Clayton PT; Lake BD; Hjelm M; Stephenson JB; Besley GT; Wanders RJ; Schram AW; Tager JM; Schutgens RB; Lawson AM
    J Inherit Metab Dis; 1988; 11 Suppl 2():165-8. PubMed ID: 3141700
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts.
    Gordon JA; Warnock LJ; Spector AA
    J Clin Invest; 1993 Jul; 92(1):169-78. PubMed ID: 7686919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential fatty acids and serine as plasmalogen precursors in relation to competing metabolic pathways.
    Cook HW; Thomas SE; Xu Z
    Biochem Cell Biol; 1991 Jul; 69(7):475-84. PubMed ID: 1793558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new variant of Zellweger syndrome with normal peroxisomal functions in cultured fibroblasts.
    Schutgens RB; Wanders RJ; Jakobs C; Arslan-Kirchner M; Miller K; Wieacker P; Hunnemann D; Hurter P; von Schutz M
    J Inherit Metab Dis; 1994; 17(3):319-22. PubMed ID: 7807942
    [No Abstract]   [Full Text] [Related]  

  • 15. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
    Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
    Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism in Zellweger's syndrome.
    Poulos A
    Prog Lipid Res; 1989; 28(1):35-51. PubMed ID: 2682669
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain.
    Sharp P; Johnson D; Poulos A
    J Neurochem; 1991 Jan; 56(1):30-7. PubMed ID: 1702833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts.
    Poulos A; Usher S; Paton BC
    Lipids; 1993 Feb; 28(2):97-102. PubMed ID: 8441343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Δ4-desaturation pathway for DHA biosynthesis is operative in the human species: differences between normal controls and children with the Zellweger syndrome.
    Martinez M; Ichaso N; Setien F; Durany N; Qiu X; Roesler W
    Lipids Health Dis; 2010 Sep; 9():98. PubMed ID: 20828389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.
    Infante JP; Huszagh VA
    Mol Cell Biochem; 1997 Mar; 168(1-2):101-15. PubMed ID: 9062899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.